Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein.
作者： Katherine A. Bush , Katherine M. Farmer , Judith S. Walker , Bruce W. Kirkham
DOI: 10.1002/ART.10173
关键词:
摘要: Objective To investigate the role of interleukin‐17 (IL‐17) in inflammatory arthritis by blockade with an IL‐17 receptor/human IgG1 Fc fusion protein (muIL‐17R:Fc) in adjuvant‐induced …
sci-hub.se 参考文章(14)
Waltraud Binder, Caroline Scott, Judith S. Walker, Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171. European Journal of Neuroscience. ,vol. 11, pp. 2065- 2072 ,(1999) , 10.1046/J.1460-9568.1999.00625.X
W. C. Fanslow, S. L. Painter, Zhengbin Yao, R. J. Armitage, D. Ulrich, B. M. Macduff, M. K. Spriggs, Human IL-17: a novel cytokine derived from T cells. Journal of Immunology. ,vol. 155, pp. 5483- 5486 ,(1995)
Maria Ziolkowska, Anna Koc, Grazyna Luszczykiewicz, Krystyna Ksiezopolska-Pietrzak, Ewa Klimczak, Hanna Chwalinska-Sadowska, Wlodzimierz Maslinski, High Levels of IL-17 in Rheumatoid Arthritis Patients: IL-15 Triggers In Vitro IL-17 Production Via Cyclosporin A-Sensitive Mechanism The Journal of Immunology. ,vol. 164, pp. 2832- 2838 ,(2000) , 10.4049/JIMMUNOL.164.5.2832
Martine Chabaud, Erik Lubberts, Leo Joosten, Wim van den Berg, Pierre Miossec, IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Research & Therapy. ,vol. 3, pp. 168- 177 ,(2001) , 10.1186/AR294
Angus W. Thomson, Shiguang Qian, William C. Fanslow, Fumin Fu, Anthony B. Troutt, Wei Li, Mary A. Antonysamy, Evidence for a Role of IL-17 in Organ Allograft Rejection: IL-17 Promotes the Functional Differentiation of Dendritic Cell Progenitors Journal of Immunology. ,vol. 162, pp. 577- 584 ,(1999)
K. A. BUSH, B. W. KIRKHAM, J. S. WALKER, The in vivo effects of tumour necrosis factor blockade on the early cell mediated immune events and syndrome expression in rat adjuvant arthritis. Clinical and Experimental Immunology. ,vol. 127, pp. 423- 429 ,(2002) , 10.1046/J.1365-2249.2002.01742.X
Dragan V. Jovanovic, Johanne Martel-Pelletier, John A. Di Battista, François Mineau, François-Cyril Jolicoeur, Mohamed Benderdour, Jean-Pierre Pelletier, Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: A possible role in rheumatoid arthritis Arthritis & Rheumatism. ,vol. 43, pp. 1134- 1144 ,(2000) , 10.1002/1529-0131(200005)43:5<1134::AID-ANR24>3.0.CO;2-#
K. A. Bush, J. S. Walker, C. S. Lee, B. W. Kirkham, Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: Interleukin-17 expression is upregulated in early disease Clinical and Experimental Immunology. ,vol. 123, pp. 487- 495 ,(2001) , 10.1046/J.1365-2249.2001.01469.X
Martine Chabaud, Pierre Miossec, The combination of tumor necrosis factor α blockade with interleukin‐1 and interleukin‐17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model Arthritis & Rheumatism. ,vol. 44, pp. 1293- 1303 ,(2001) , 10.1002/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T
Rutger L. Van Bezooijen, Hetty C. M. Farih-Sips, Socrates E. Papapoulos, Clemens W. G. M. Löwik, Interleukin-17: A new bone acting cytokine in vitro. Journal of Bone and Mineral Research. ,vol. 14, pp. 1513- 1521 ,(1999) , 10.1359/JBMR.1999.14.9.1513